AwardedCzechiaGoodsCZK 141,891,000
Antivirotika HCV – Sofosbuvir - Velpatasvir - II.
- Published
- Published 13 April 2026
- Deadline
- Closed 12 May 2026
Overview
The Institut klinické a experimentální medicíny (Institute of Clinical and Experimental Medicine) procured antiviral medications containing sofosbuvir and velpatasvir (ATC J05AP55) for treating patients in approved indications. Gilead Sciences s.r.o. was awarded the contract on 14 May 2026 for 141,890,448.7 CZK.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 141,891,000
- Procedure
- Open
- Published
- 13 April 2026
- Deadline
- Closed
Antivirals for systemic use
Award outcome
- Awarded value
- CZK 141,890,449
- Award date
- 14 May 2026
- Contract period
- — → 23 April 2030
- Gilead Sciences s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 June 2026
Contract Notice
13 April 2026
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.